Back to search

Article

AMPK activation by metformin promotes survival of dormant ER+ breast cancer cells

2020-01-28

Abstract excerpt

<h4>Purpose</h4> Despite adjuvant anti-estrogen therapy for patients with estrogen receptor alpha (ER)-positive breast cancer, dormant residual disease can persist for years and eventually cause tumor recurrence. We sought to deduce mechanisms underlying the persistence of dormant cancer cells to identify therapeutic strategies. <h4>Experimental Design</h4> Mimicking the aromatase inhibitor-induced depletion of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d665dc10-3926-577b-b27e-0a2f3030e3ca
DOI
10.1101/2020.01.21.914382
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
AMPK activation by metformin promotes survival of dormant ER+ breast cancer cellsDOI 10.1101/2020.01.21.914382
Select a neighboring publication to make it the new centre.